Your browser doesn't support javascript.
loading
A 25 year perspective on the evolution and advances in an understanding of the biology, evaluation and treatment of kidney cancer.
Geynisman, Daniel M; Maranchie, Jodi K; Ball, Mark W; Bratslavsky, Gennady; Singer, Eric A.
Afiliação
  • Geynisman DM; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA. Electronic address: daniel.geynisman@fccc.edu.
  • Maranchie JK; Department of Urology, University of Pittsburgh, Pittsburgh, PA.
  • Ball MW; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Bratslavsky G; Department of Urology, SUNY Upstate Medical University, Syracuse, NY.
  • Singer EA; Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey and Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ.
Urol Oncol ; 39(9): 548-560, 2021 09.
Article em En | MEDLINE | ID: mdl-34092483

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células de Transição / Pesquisa Biomédica / Neoplasias Renais Limite: Humans Idioma: En Revista: Urol Oncol Assunto da revista: NEOPLASIAS / UROLOGIA Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células de Transição / Pesquisa Biomédica / Neoplasias Renais Limite: Humans Idioma: En Revista: Urol Oncol Assunto da revista: NEOPLASIAS / UROLOGIA Ano de publicação: 2021 Tipo de documento: Article